Prestige Consumer Healthcare Inc. (PBH)
NYSE NYSE Primary 
XFRA 
PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%
Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Company Susan Anderson - Canaccord Genuity Keith Devas - Jefferies David Shakno - William Blair Linda Bolton Weiser - D. A. Davidson Anthony Lebiedzinski - Sidoti & Company Operator Thank you for standing by, and welcome to Prestige Consumer Healthcare's Third Quarter 2025 Earnings Conference Call.
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago.
PBH vs. BSX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge?
PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.
PBH or BSX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
PBH vs. BSX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
Investors remain optimistic about PBH stock due to its strong focus on brand building.
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border
Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a portfolio mix of proteins, baked goods, and distribution, with 70% sales from foodservice and retail chains. The macro environment suggests lower interest rates, but inflation and wage increases could impact PBH's middle and low-income customer base.
PBH or SYK: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
PBH vs. SYK: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
